Based on MSF’s field experience and needs, we are pushing for better coverage with existing vaccines like measles and for cheaper and better adapted versions of new vaccines.

11. March 2016.

MSF launches challenge to Pfizer's patent on the pneumonia vaccine in India

This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organisation, with the goal of millions more children being protected against deadly pneumonia.
Read more


Vaccines: The Issues

Niger © Olivier Asselin

Learn about the issues involved in developing vaccines that work for developing coutries and supporting wide immunisation coverage.

» Read more

Featured multimedia

Help Us #AskPharma to Make Vaccines Affordable
MSF led a protest in front of Pfizer's world headquarters in New York City and attended the company's shareholders' meeting in New Jersey demanding they and GSK slash the price of pneumococcal vaccine in developing countries and disclose what they currently charge countries for the vaccine...

Tags: Pfizer, pneumococcal vaccine, pneumonia, vaccine, access to medicines, drug prices

Spotlight on…

↑ To top